NYSE: CVRS PRICE: 1.25 -0.04 -3.1% Volume: 416,462 20 minute delay. November 8, 2018

Press Releases

Corindus to Present at 13th Annual Wells Fargo Securities Healthcare Conference

August 23, 2018

WALTHAM, Mass.--(BUSINESS WIRE)-- Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that Mark Toland, President and Chief Executive Officer, will present at the 13th Annual Wells Fargo Securities Healthcare Conference. Details for the presentation include:

Date     September 5, 2018
Time     3:35pm EDT
Location     The Westin Copley Place, Boston


The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the company’s website at investors.corindus.com, under the News & Events Section.

About Corindus Vascular Robotics

Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company's CorPath® System is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary and percutaneous vascular procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance guide catheters, stents, and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. CorPath GRX is the second generation robotic-assisted PCI technology offering enhancements to the platform by adding important key upgrades that increase precision, improve workflow, and extend the capabilities and range of procedures that can be performed robotically. With the CorPath System, Corindus Vascular Robotics brings robotic precision to interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement during manual procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program." For additional information, visit www.corindus.com, and follow @CorindusInc.

Corindus Vascular Robotics, Inc.
Media Contact:
Kate Drake, T: 508-653-3335 ext. 200
In-Site Communications, Inc.
Investor Contact:
Lisa Wilson, 917-543-9932

Source: Corindus Vascular Robotics, Inc.

Email Alerts

Mailing Lists *

Email Address *

Enter the code shown above.

Investor Contact

Scott Madden
508-653-3335 Ext 504